Interviews

Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences

by Andrii Buvailo, PhD  (contributor )   •     

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on life at its most basic level. Dr. Markus Gershater, Co-founder and Chief Science Officer of Synthace, sheds light on the challenges and opportunities this union presents. Synthace, a UK-based no-code platform, allows for the design and execution of experiments, subsequently producing and analyzing structured data.

With AI's potential to revolutionize our approach to biological systems, it also highlights the need for a change in our scientific methods and thinking. As past technological shifts like electrification have taught us, simply adopting new technology isn't the end game. The true value emerges when technology is paired with new approaches and perspectives. In this interview, Dr. Gershater discusses a future where AI becomes an integral part of biology, not just an adjunct.

#advertisement
AI in Drug Discovery Report 2025

Continue reading

This content available exclusively for BPT Mebmers

Topics: AI & Digital   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email